WNT Pathway Activation Predicts Increased Risk of Tumor Recurrence in Patients With Stage I Nonsmall Cell Lung Cancer
Annals of Surgery - United States
doi 10.1097/sla.0b013e31826d81fd
Full Text
Open PDFAbstract
Available in full text
Categories
Date
March 1, 2013
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)